High RUNX1 expression levels were linked to worse OS and DFS in CESC, COAD, GBM, KIRC, brain lower-grade glioma (LGG), and uveal melanoma (UVM), but were related to better OS and DFS in BRCA. This evidence concerns the gene RUNX1 and glioblastoma.